Baird Medical Investment (BDMD) vs SeaStar Medical (ICU)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
SeaStar Medical (ICU) has outperformed Baird Medical Investment (BDMD) over the past year, losing 69.3% versus a loss of 93.6%. Baird Medical Investment is the larger company by market cap ($5.1 million vs $5.0 million), about 1.0 times the size, while SeaStar Medical is growing revenue faster (+814.1% vs -39.2%). Baird Medical Investment converts more of its revenue into profit, with a net margin of -121.0% versus -984.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BDMD | ICU |
|---|---|---|
| Share price | $0.0897 | $0.935 |
| Market cap | $5.07M | $4.97M |
| 1-day change | -12.91% | -10.95% |
| YTD return | -93.40% | -61.04% |
| 1-year return | -93.64% | -69.34% |
| 5-year return | — | -99.96% |
| Forward P/E | 0.64 | — |
| EPS (TTM) | $-0.55 | $-2.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $22.54M | $1.23M |
| Revenue growth (YoY) | -39.15% | +814.07% |
| Net income (latest FY) | $-27.28M | $-12.15M |
| Gross margin | 83.79% | 95.71% |
| Operating margin | -113.73% | -986.63% |
| Net margin | -121.04% | -984.60% |
| 52-week high | $3.70 | $5.38 |
| 52-week low | $0.073 | $0.761 |
| Distance from 52-week high | -97.58% | -82.62% |
| Analyst consensus | none | none |
| Avg. price target upside | +4359.31% | +969.52% |
| Average volume | 16.31M | 196.27K |
| Shares outstanding | 56.52M | 5.32M |
| Employees | 146 | 18 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ICU has outperformed BDMD by 24.3 percentage points over the past year.
- Baird Medical Investment is more profitable, keeping -121.0 cents of every revenue dollar as net income versus -984.6 cents for SeaStar Medical.
- SeaStar Medical grew revenue faster in its latest fiscal year (+814.07% vs -39.15%).
About Baird Medical Investment
BDMD stock →Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation.
Health Care · Medical/Dental Instruments · 146 employees
About SeaStar Medical
ICU stock →SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis.
Health Care · Medical/Dental Instruments · 18 employees
BDMD vs ICU FAQ
Which is bigger, Baird Medical Investment or SeaStar Medical?
Baird Medical Investment (BDMD) is larger, with a market capitalization of $5.07M compared with $4.97M for SeaStar Medical (ICU).
Which stock has performed better over the past year, BDMD or ICU?
ICU returned -69.34% over the past 12 months, compared with -93.64% for BDMD (price return, excluding dividends). Past performance does not predict future results.
Are Baird Medical Investment and SeaStar Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.